Cargando…

Factors Governing the Erythropoietic Response to Intravenous Iron Infusion in Patients with Chronic Kidney Disease: A Retrospective Cohort Study

Background: Limited knowledge exists about factors affecting parenteral iron response. A study was conducted to determine the factors influencing the erythropoietic response to parenteral iron in iron-deficient anaemic patients whose kidney function ranged from normal through all stages of chronic k...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chukwu, Chukwuma A., Gilbody, Helen, Wickens, Olivia, Carroll, Craig, Bhandari, Sunil, Kalra, Philip A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525177/ https://www.ncbi.nlm.nih.gov/pubmed/37760860 http://dx.doi.org/10.3390/biomedicines11092417

Ejemplares similares

Safety of intravenous iron use in chronic kidney disease
por: Kalra, Philip A., et al.
Publicado: (2016)

Analysis of oxidative stress, inflammation and endothelial function following intravenous iron in chronic kidney disease in the Iron and Heart Trial
por: Kassianides, Xenophon, et al.
Publicado: (2022)

The Impact of Intravenous Iron on Renal Injury and Function Markers in Patients With Chronic Kidney Disease and Iron Deficiency Without Anemia
por: Kassianides, Xenophon, et al.
Publicado: (2021)

Clinical and biochemical improvement following low-dose intravenous iron therapy in a patient with erythropoietic protoporphyria
por: Bentley, Douglas P, et al.
Publicado: (2013)

Iron infusion and newer intravenous iron formulations
por: Aung, Tim, et al.
Publicado: (2021)

Efficacy and safety of iron isomaltoside (Monofer(®)) in the management of patients with iron deficiency anemia
por: Kalra, Philip A, et al.
Publicado: (2016)

Effects of Iron Supplementation on Erythropoietic Response in Patients with Cancer-Associated Anemia Treated by Means of Erythropoietic Stimulating Agents
por: Karlsson, Torbjörn
Publicado: (2011)

Intravenous Irons: From Basic Science to Clinical Practice
por: Bhandari, Sunil, et al.
Publicado: (2018)

Impact of Intravenous Iron on Oxidative Stress and Mitochondrial Function in Experimental Chronic Kidney Disease
por: Nuhu, Faisal, et al.
Publicado: (2019)

Iron, Heme Synthesis and Erythropoietic Porphyrias: A Complex Interplay
por: Poli, Antoine, et al.
Publicado: (2021)

Erythropoietic protoporphyria
por: Lecha, Mario, et al.
Publicado: (2009)

A multicentre prospective double blinded randomised controlled trial of intravenous iron (ferric Derisomaltose (FDI)) in Iron deficient but not anaemic patients with chronic kidney disease on functional status
por: Bhandari, S., et al.
Publicado: (2021)

The safety of accelerated infusion versus standard rate infusion of low-molecular-weight iron dextran in patients with chronic kidney disease
por: Sinha, Smeeta, et al.
Publicado: (2009)

Erythropoietic response to oral iron in patients with nondialysis-dependent chronic kidney disease in the FIND-CKD trial
por: Macdougall, Iain C., et al.
Publicado: (2017)

The comparative effects of intravenous iron on oxidative stress and inflammation in patients with chronic kidney disease and iron deficiency: a randomized controlled pilot study
por: Kassianides, Xenophon, et al.
Publicado: (2021)

Safety and efficacy of iron isomaltoside 1000/ferric derisomaltose versus iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparative trial
por: Bhandari, Sunil, et al.
Publicado: (2020)

ERYTHROPOIETIC CELL CULTURES FROM CHICK EMBRYOS
por: Hagopian, Helen K., et al.
Publicado: (1972)

Microcytosis in Erythropoietic Protoporphyria
por: Graziadei, Giovanna, et al.
Publicado: (2022)

Patient reported outcome measures and cardiovascular outcomes following high dose modern intravenous iron in non-dialysis dependent chronic kidney disease: secondary analysis of ExplorIRON-CKD
por: Kassianides, Xenophon, et al.
Publicado: (2023)

A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia
por: Kalra, Philip A., et al.
Publicado: (2016)

Protocol and baseline data for a prospective open-label explorative randomized single-center comparative study to determine the effects of various intravenous iron preparations on markers of oxidative stress and kidney injury in chronic kidney disease (IRON-CKD)
por: Ziedan, Ahmed, et al.
Publicado: (2019)

Kidney Transplant-Associated Viral Infection Rates and Outcomes in a Single-Centre Cohort
por: Pullerits, Kairi, et al.
Publicado: (2022)

Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease
por: Koury, Mark J., et al.
Publicado: (2022)

Transfusional iron overload and intravenous iron infusions modify the mouse gut microbiota similarly to dietary iron
por: La Carpia, Francesca, et al.
Publicado: (2019)

Analysis of Adverse Events and Intravenous Iron Infusion Formulations in Adults With and Without Prior Infusion Reactions
por: Arastu, Asad H., et al.
Publicado: (2022)

Erythropoietic Factor in Human Mixed Saliva
por: Sitaramamurti, A.
Publicado: (1941)

Correction to: Protocol and baseline data for a prospective open-label explorative randomized singlecenter comparative study to determine the effects of various intravenous iron preparations on markers of oxidative stress and kidney injury in chronic kidney disease (IRON-CKD)
por: Ziedan, Ahmed, et al.
Publicado: (2020)

THE ERYTHROPOIETIC ACTION OF GERMANIUM DIOXIDE
por: Hammett, Frederick S., et al.
Publicado: (1922)

Erythrodontia in congenital erythropoietic porphyria
por: Bhavasar, Rashmi, et al.
Publicado: (2011)

DNA SYNTHESIS AND MITOSIS IN ERYTHROPOIETIC CELLS
por: Grasso, Joseph A., et al.
Publicado: (1967)

A pilot study of oral iron therapy in erythropoietic protoporphyria and X-linked protoporphyria
por: Balwani, Manisha, et al.
Publicado: (2022)

UK experience of liver transplantation for erythropoietic protoporphyria
por: Dowman, Joanna K., et al.
Publicado: (2011)

NIMO-CKD-UK: a real-world, observational study of iron isomaltoside in patients with iron deficiency anaemia and chronic kidney disease
por: Kalra, Philip A., et al.
Publicado: (2020)

Evaluating the antibody response to SARS-COV-2 vaccination amongst kidney transplant recipients at a single nephrology centre
por: Chukwu, Chukwuma A., et al.
Publicado: (2022)

High-dose intravenous iron reduces myocardial infarction in patients on haemodialysis
por: Petrie, Mark C, et al.
Publicado: (2021)

Safety of ferric derisomaltose and iron sucrose in patients with iron deficiency anemia: The FERWON‐IDA/NEPHRO trials
por: Wolf, Myles, et al.
Publicado: (2020)

Massive Intravenous Infusions
por: Harrison, William, et al.
Publicado: (1954)

Compression of the Lateral Antebrachial Cutaneous Nerve due to Leakage of Iron after an Intravenous Iron Infusion
por: Kwak, Soyoung, et al.
Publicado: (2020)

Iron deposition in autopsied liver specimens from older patients receiving intravenous iron infusion
por: Akatsu, Hiroyasu, et al.
Publicado: (2020)

Host iron status and erythropoietic response to iron supplementation determines susceptibility to the RBC stage of falciparum malaria during pregnancy
por: Goheen, Morgan M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_375pkajj0nj07o86r9ni2ih4ib